Cheryl A. Moore, President and Chief Operating Officer of the New York Genome Center (NYGC), has been named to the Crain’s New York Business list of 2020 Notable in Health Care. This is the second consecutive year that Ms. Moore has been recognized by Crain’s, having been selected as one of its Notable Women in Health Care in 2019. The list of the 2020 honorees, who are being recognized for outstanding leadership in the health care field, appears in the August 10 issue.
Ms. Moore is responsible for overseeing NYGC’s financial and operational functions and working together with Evnin Family Scientific Director and Chief Executive Officer Tom Maniatis, PhD, in setting the strategic direction of the organization. The NYGC is an independent, nonprofit research institution focused on disease-focused research to better understand the genetic basis of cancer, neurodegenerative diseases, and neuropsychiatric diseases, including the development of advanced computational and experimental genomic methods. The Center serves as a nexus for collaboration in genomic research for the New York community and beyond, building on the combined strengths of its faculty, member institutions, scientific working groups, affiliate members, and industry partners. Most recently, the Center has expanded its research to include the study of the genomics underlying the host-pathogen biology of SARS-CoV-2 and associated COVID-19 disease, and has expanded its clinical lab to perform SARS-CoV-2 virus testing for the community.
With her diverse experience as both a founder and change leader in the for-profit and nonprofit arenas, Ms. Moore is known for her strategic ability to resolve performance bottlenecks, develop innovation-intense environments, implement systems, and rationalize operations. Throughout her career, she has applied these skills across organizations at differing levels of maturity in the fields of health care, technology, biomedical research, and financial services, bringing more than twenty years of strategic executive experience in collaborative leadership involving some of the world’s highest-performing scientists and physicians.
Ms. Moore has a long history and extensive experience in leading research organizations. Before joining the NYGC, she served for six years as the Executive Vice President and Chief Operating Officer of the Howard Hughes Medical Institute (HHMI), a $19B medical research organization, where she led collaborative strategic efforts and supervised key operational functions. From 2004 until 2010, she served as the founding Chief Operating Officer of HHMI’s Janelia Research Campus, an innovative research hub in Northern Virginia, where she played a pivotal role in Janelia’s launch. At Janelia, Ms. Moore guided development and implementation of its operating strategy, overseeing all operational aspects of the campus and its over $100M annual budget. Prior to joining HHMI, Ms. Moore served as Senior Vice President and Chief Operating Officer of the Sanford-Burnham Prebys Medical Discovery Institute in La Jolla, California and previously held top management positions in both start-up and public health care companies that experienced intense periods of growth. Prior to her work in biomedical research, she served as a C-Suite leader at a health care company that grew from $5M to $1B over five years through acquisitions, and then helped the company prepare for its initial public offering.
Ms. Moore has led nonprofit and industry initiatives both domestically and internationally. She has long supported economic development and was appointed by Governor Andrew M. Cuomo to serve as Co-Chair of the New York City Regional Economic Development Council and has previously served on the Board of the Economic Club of Washington, DC. She has also been appointed by government officials to serve on the Grant Allocation Committee of the Commonwealth Technology Research Fund and on the Virginia Biotechnology Research Park Authority Board. Ms. Moore currently serves on the boards of the Sainsbury Wellcome Centre for Neural Circuits and Behaviour, Genome Research Limited, and the Association of Independent Research Institutes, and previously served as Co-Chair of the Virginia Governor’s Biosciences Strategic Initiatives Task Force, and on the Board of the Virginia Biotechnology Association. Frequently tapped as strategic advisor, Ms. Moore has served on the Advisory Boards of the Human Vaccines Project, the Krasnow Institute for Advanced Study at George Mason University, and the Virginia Science and Technology Campus of George Washington University and has chaired the Wellcome Trust’s Science Strategy Advisory Group.
